Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kitron Director's Dealing 2017

Feb 20, 2017

3643_dirs_2017-02-20_0dbed79a-c4e2-4d09-abbd-e11384de76eb.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Kitron ASA: Mandatory notification of trade

  1. February 2017. Reference is made to Kitron ASA's stock exchange notice dated 25 October 2016 about issuance of shares under the company's share incentive program for executive management. The shares are subject to trading restrictions allowing a maximum of one eight of the shares to vest and become tradable each quarter.

The following members of Kitron ASA's management group have on 20. February 2017 sold the following number of shares received according to the program:

Name Position Shares sold Remaining holdings of
shares
Thomas Löfgren MD Sweden 35 755 250 286
Tommy P. Storstein Sales director 37 147 260 029
Mindaugas Sestokas MD Lithuania 56 544 395 809
Hans Petter Thomassen MD Norway 22 155 155 087

The shares were sold at an average price of NOK 6,8852.

Kitron is one of Scandinavia's leading electronics manufacturing services companies for the Defence/Aerospace, Energy/Telecoms, Industry, Medical devices and Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania, Germany, China and the United States. Kitron had revenues of about NOK 2.1 billion in 2016 and has about 1 350 employees. www.kitron.com